Clinical Trial Update: Creatine to Augment Bioenergetics in Alzheimer's [NA]

View source ↗

Summary

This clinical trial update confirms the completion of a study evaluating creatine to augment brain bioenergetics in Alzheimer's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Creatine (creatine)

Snippet

Sponsor: University of Kansas Medical Center | Conditions: Alzheimer's Disease | NA | Status: COMPLETED